首页 | 本学科首页   官方微博 | 高级检索  
     

COS/TPC同源重组法高效制备人B7(CD80)重组腺病毒
引用本文:章卫平,曹雪涛,滨田洋文. COS/TPC同源重组法高效制备人B7(CD80)重组腺病毒[J]. 中国肿瘤生物治疗杂志, 1997, 4(1): 10-13
作者姓名:章卫平  曹雪涛  滨田洋文
作者单位:Laboratoryofpathology,CancerInstitute,HokkaidoUniversitySchoolofMedicine,Kita-15,Nishi-7,Kita-ku,Sapporo060,Japan,Laboratoryofpathology,CancerInstitute,HokkaidoUniversitySchoolofMedicine,Kita-15,Nishi-7,Kita-ku,Sapporo060,Japan,Laboratoryofpathology,CancerInstitute,HokkaidoUniversitySchoolofMedicine,Kita-15,Nishi-7,Kita-ku,Sapporo060,Japan
基金项目:国家九五科技攻关项目(969060120)资助
摘    要:本研究探讨了FN对LAK细胞活性的影响.Extracellular Matrix Protein(ECM)中的一种成分FN是基底膜、细胞间质及细胞表面的重要组成成分.本文发现FN能调节LAK细胞的功能.首先、LAK细胞和FN的粘付能力被增强.第二、经过与FN共同培养的LAK细胞活性比正常要高15~20%左右.FN对LAK细胞活性增强机理是通过激活LAK细胞表面的LFA-1的活性(不是LFA-1数量的增加)来增强LAK细胞和肿瘤细胞的结合功能、提高LAK细胞的杀伤肿瘤细胞的能力.本文的结果表明FN-LAK可能会改善肿瘤治疗效果、并间接提示肿瘤细胞表面及肿瘤组织中的FN成分的多少可直接影响LAK细胞的治疗效果.

关 键 词:共刺激分子; B7; 腺病毒载体; 基因转移; 基因表达
收稿时间:1996-10-20
修稿时间:1996-12-30

Efficient Generation of Human B7(CD80) Recombinant Adenovirus by COS/TPC Homologous Recombination
Zhang Weiping,Cao Xuetao and Hamada Hirofumi. Efficient Generation of Human B7(CD80) Recombinant Adenovirus by COS/TPC Homologous Recombination[J]. Chinses Journal of Cancer Biotherapy, 1997, 4(1): 10-13
Authors:Zhang Weiping  Cao Xuetao  Hamada Hirofumi
Affiliation:Yong-Qing Li,Masanobu Kobayashi,Yasuhiro Kuramitsu,Lan Yuan,Kazuhi-ro Matsushit,Hideo Yagita ~#,Ko Okumura ~# and Masuo Hosokawa
Abstract:In this study, we demonstrated that immobilized fibronectin (FN) enhanced LAK activity, and that the enhanced LAK activity was completely abrogated by an anti-VLA-5 monoclonal antibody and RGD peptide. Fresh -spleen cells expressed VLA-4, VLA-6 and vitronectin receptor, whereas VLA-5 was expressed only on the spleen cells activated with IL-2. LAK cells showed increased adhesion to immobilized FN compared with that to control BSA, and the increased adhesion of LAK cells to immobilized FN was inhibited by anti-VLA-5 monoclonal antibody. Conjugate-formation assay showed that the LAK cells cultured on immobilized FN bound to target cells more efficiently than the control LAK cells, and that anti-LFA-1 monoclonal antibody inhibited the LAK-target cell binding. Immobilized type IV collagen and laminin, as well as FN, enhanced LAK activity. All these results suggest that the interaction of inte-grins expressed on LAK cells with extracellular matrix proteins act as co-stimulator for the enhancement of LAK activity , and that anchorage is necessary for full activation of LAK cells.
Keywords:lymphokine activated killer(LAK) activity  extracellular matrix protein  adhesion molecule
本文献已被 CNKI 等数据库收录!
点击此处可从《中国肿瘤生物治疗杂志》浏览原始摘要信息
点击此处可从《中国肿瘤生物治疗杂志》下载全文
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号